Certara Adopts TrialAssure ANONYMIZE Solution to Speed Life Science Industry Need to Meet Regulatory Requirements for Data Sharing

TrialAssure® – a leading, global software company advancing clinical trial disclosure, data sharing, and transparency – has announced today that Certara (Nasdaq: CERT) – the global leader in biosimulation – has licensed TrialAssure’s ANONYMIZE software to anonymize clinical data.

Future Planet Invests in Vaccitech’s Series B Financing

Future Planet Capital has invested in a $168m Series B financing announced today by Vaccitech Ltd.

Pronalyse: Antibody Analysis Service Is Released to Boost Drug Discovery

CRISPR/Cas9 Gene Editing Service Now Available by the GutFlora Omics Platform

Bioinformatics-Analysis Division Revised Website for Better User Experience

MicrobioSeq Releases Microecology and Cancer Solutions to Accelerate Your Cancer Research and Discovery

THREAD Launches New Telehealth Features Expanding Video and Audio Capture for Complex eCOA during Virtual Visits in Decentralized Clinical Trials

THREAD, a technology and service provider enabling decentralized clinical trials (DCTs), today announced the launch of new telehealth features. Building on four years of conducting electronic clinical outcome assessments (eCOA) during telehealth virtual visits, the new features raise the bar in DCT telehealth functionality by adding several unique enhancements to the company’s industry-leading eCOA and telehealth virtual visit solution. New features allow clinical study stakeholders – including sponsors, caregivers, home health professionals and raters – to remotely and safely capture video and/or audio recordings in real time.

RDIF and Stelis Biopharma partner to supply 200 million doses of the Sputnik V vaccine

Notes to editors Russian Direct Investment Fund (RDIF) is Russia's sovereign wealth fund established in 2011 to make equity co-investments, primarily in Russia, alongside reputable international financial and strategic investors. RDIF acts as a catalyst for direct investment in the Russian economy. RDIF’s management company is based in Moscow. RDIF has established joint strategic partnerships with leading international co-investors from over 18 countries attracting over $40 bn of capital. Further information can be found at rdif.ru For more information about the Sputnik vaccine please visit sputnikvaccine.com/ Stelis Biopharma Pvt. Ltd. (Stelis) is a vertically integrated biopharmaceutical company. Stelis offers end-to-end state-of-the-art CDMO services across all phases of pre-clinical and clinical development and commercial supply of biologics. Its operations include R&D, process development, scale-up & end-to-end cGMP manufacturing capabilities from drug substance through drug product in all formats and packaging. Stelis is also developing select follow-on biologic products for global markets in niche and commercially attractive disease categories. Stelis has recently forayed into Vaccine manufacturing with a capability to do multiple vaccine types. Stelis’ state-of-the-art research & development facility and 200,000 sq. ft. fully integrated cGMP manufacturing facility are located in Bengaluru, India. Facilities cater to the development and cGMP manufacturing of biologics and injectables conforming to international standards. For more information visit www.stelis.com Strides, listed on the BSE Limited (532531) and National Stock Exchange of India Limited (STAR), is a global pharmaceutical company headquartered in Bengaluru, India. The Company mainly operates in the regulated markets and has an “in Africa for Africa” strategy along with an institutional business to service donor-funded markets. The Company’s global manufacturing sites are located in India (Chennai, Puducherry and two locations in Bengaluru), Singapore, Italy (Milan), Kenya (Nairobi) and the United States (Florida). The Company focusses on “difficult to manufacture” products that are sold in over 100 countries. Additional information is available at the Company’s website at www.strides.com

Irish Company Develops Cloud-Based App Aimed to Accelerate Global COVID-19 Vaccination Process

Samsung Biologics Unveils Strong Performance and Future Plans

As the company celebrates its 10th anniversary this year, it is pleased to announce a strong 2020, reporting 1 Trillion won in sales!

Shimmer Launches Pulse+ the First Line Extension for its Verisense® Wearable Sensing Platform for Clinical Trials

Shimmer’s Verisense platform can now measure clinical trial participants’ heart rate, oxygen saturation and emotional responses in addition to their activity and sleep levels.

MDI Biological Laboratory Receives Funding to Address Arsenic Threat

The MDI Biological Laboratory will collaborate with the Maine Center for Disease Control and Prevention, an office of the state Department of Health and Human Services, on a five-year grant from the federal Centers for Disease Control and Prevention (CDC), to improve access to safe drinking water in Maine.

Alfa Chemistry Released Ion Sensor Materials for Analytical and Chromatography Applications

Dotmatics announces licensing agreement for informatics software with Compugen

Compugen selects Dotmatics’ cloud-based LIMS and ELN solution to drive efficient drug discovery Agreement marks the first implementation of Dotmatics SaaS technology in Israel, further extending global access

IDT Launches rhAmpSeq™ CRISPR Analysis System

Integrated DNA Technologies (IDT) has launched its rhAmpSeq™ CRISPR Analysis System, which offers an end-to-end solution for characterizing and quantifying the full array of on- and off-target genome editing events in CRISPR research projects.

AARDEX and Schreiner MediPharm reinforce their collaboration to Enhance Medication Adherence Management

AARDEX Group, the world leader in medication adherence solutions, continues to build up its ecosystem and to bridge GMP to GCP world in Clinical Trials by reinforcing their strategic partnership with Schreiner MediPharm, a global specialist in innovative functional labels and smart packaging solutions for the pharmaceutical industry.

CARLSBAD, Calif. – Thermo Fisher Scientific Launches 3,000 L and 5,000 L HyPerforma DynaDrive Single-Use Bioreactors (S.U.B.s) for Cell Culture Production

Further European expansion for G&L Scientific

Regulatory Affairs experts, G&L Scientific, have announced further expansion in Europe with new dedicated client services in Spain, Italy, Germany and France.

SB3000 ApS has been awarded a grant from the Danish Innovation Fund, to further refine its continuous manufacturing enabling technology μLOT® which will revolutionise the production of medicines

SB3000 is to receive grant funding from the Danish Innovation Fund to support its continuous manufacturing enabling technology for medicine production.

Northeast Georgia Health System Elevates Its Digital Consumer Experience with Self-Service Capabilities from Kyruus